A Chemo-Optogenetic Nanosensor For The Control Of Drug-Resistant Epilepsy (Ph4Health)

Universities and Institutes of Italy
December 31, 2023
Contact:N/A
Offerd Salary:Negotiation
Location:N/A
Working address:N/A
Contract Type:Other
Working Time:Full time
Working type:N/A
Ref info:N/A

12 Oct 2023

Job Information

Organisation/Company

University of Trieste

Department

Department of Life Sciences

Research Field

Neurosciences » Neurobiology

Researcher Profile

First Stage Researcher (R1)

Country

Italy

Application Deadline

31 Dec 2023 - 12:00 (Europe/Rome)

Type of Contract

Temporary

Job Status

Full-time

Offer Starting Date

1 Feb 2024

Is the job funded through the EU Research Framework Programme?

Not funded by an EU programme

Is the Job related to staff position within a Research Infrastructure?

No

Offer Description

We seek motivated applicants for a pre-doctoral / post-doctoral fellowship aimed at developing a novel chemo-optogenetic tool for drug-refractory epilepsy. The project will optimize ad-hoc probes that will sense extracellular acidic pH shifts associated with epileptic activity and optogenetically silence excitatory neurons to inhibit seizure generation. For the in vitro approach, the successful applicant will have a background in cellular / molecular neurobiology and molecular cloning, with some experience in culturing primary neurons and astroglia. For more information and to send your application, please contact Dr. Fabrizia Cesca at [email protected] by December 31 st, 2023. Please note that the starting date is flexible. Below a detailed abstract of the Research Project.

Epilepsy is a neurological disorder characterized by repeated seizures. Several therapeutic approaches are available but, unfortunately, around 30% of patients do not respond to medical therapies. In the last decade, optogenetics has emerged as a tool to both explore neuronal networks dynamics and to treat neurological conditions such as epilepsy. The optogenetic strategy is based on the expression, in precise brain areas, of light-sensitive proteins called opsins that are able to change the membrane potential upon wavelength-specific illumination, usually achieved using invasive optical fibers. Despite the many advantages of this technique, it still faces practical and translational challenges because of the difficulties of illuminating multiple and deep areas of the brain. In this scenario, the search of alternative light sources is an unmet need.

Luciferases are enzymes able to emit light upon addiction of their substrate coelenterazine and can be used to deliver endogenously generated light to opsins and modulate their action non-invasively. In this project, we aim to develop a closed-loop chemo-optogenetic nanomachine called pHIL (pH-sensitive inhibitory luminopsin) that senses the extracellular acidic pH shifts associated with epileptic activity and optogenetically silences excitatory neurons to inhibit seizure generation. In fact, seizure activity leads to an extracellular pH shifts toward acidosis, which in turn aggravates hyperexcitability by stimulating depolarizing acid-sensing ion channels. A triple chimeric probe pHIL has been designed in which a bioluminescent variant of Renilla luciferase (RLuc8) is coupled to a fluorescent pH sensor (EGFP mutant, called E2GFP) and the inhibitory opsin eNpHR3.0. In the proposed strategy, under acidic pH evoked by hyperexcitation, the fluorescence emission of E2GFP excited by endogenous RLuc8 UV-light will increase, in turn activating eNpHR3.0 to actuate a hyperpolarizing outward current that delays/silence epileptic activity. A first pHIL1.0 chimera has already been engineered and expressed in cell lines and primary hippocampal neurons. On the basis of promising preliminary data, we will: (i) optimize the chimera for optimal energy transfer between its building blocks; (ii) study the activation of the inhibitory opsin by the acidic pH in cell lines and primary neurons; (iii) express pHIL in the hippocampus and study pHIL responses to epileptic-like activity in cortico-hippocampal slices; (iv) test the efficacy of pHIL in vivo on drug-evoked tonic-clonic seizures and in experimental models of genetic epilepsy. We propose pHIL as a cell-autonomous close-loop nanomachine to counteract neuronal hyperexcitability and restore neural network homeostasis in drug-resistant epilepsy.

Requirements

Research Field

Neurosciences » Neurobiology

Education Level

Master Degree or equivalent

Research Field

Neurosciences » Neurobiology

Education Level

PhD or equivalent
Additional Information Work Location(s)

Number of offers available

1

Company/Institute

University of Trieste

Country

Italy

City

Trieste

Postal Code

34127

Street

Piazzale Europa, 1

Geofield

Where to apply

E-mail

[email protected]

Contact

City

Trieste

Website

https: // www. units.it/

Street

Piazzale Europa, 1

Postal Code

34127

STATUS: EXPIRED

From this employer

Recent blogs

Recent news